69. Efficient Synthesis of Frutinone A and Its Derivatives via Palladium-Catalyzed C-H Activation/Carbonylation
Shin, Y.; Yoo, C.; Moon, Y.; Lee, Y.; Hong, S.
Chem.-Asian J. 2015, 10, 878.
(Invited Article for 'The 10th Anniversary of the Asian Core Program (ACP)' themed collection)
68. HS-543 Induces Apoptosis of Imatinib-Resistant Chronic Myeloid Cells with T315I Mutation
Kim, S.-J.; Jung, K. H.; Yan, H. H., Son, M.-K.; Fang, Z.; Ryu, Y.-L.; Lee, H.; Kim, J.; Lee, S.; Hong, S.*; Hong, S.-S.*
ONCOTARGET 2015, 6, 1507-1518.
67. Anticancer Activity of HS-527, a Novel Inhibitor Targeting PI3-Kinase in Human Pancreatic Cancer Cells
Ryu, Y.-L.; Jung, K. H.; Son, M. K.; Yan, H. H.; Kim, S. J.; Shin, S.; Hong, S.*; Hong, S.-S.*
Cancer Lett. 2014, 353, 68.
66. HS-133, a Novel Fluorescent Phosphatidylinositol 3-Kinase Inhibitor as a Potential Imaging and Anticancer Agent for Targeted Therapy
Lee, J.-H.; Jung, K. H.; Lee, H.; Yun, S.-M., Son, M.-K.; Ahn, S.-H.; Lee, S.; Kim, D.; Hong, S.*; Hong, S.-S.*
ONCOTARGET 2014, 5, 10180.
65. Copper-Mediated Cross-Coupling Approach for the Synthesis of 3-Heteroaryl Quinolone and Related Analogues
Shin, S.; Kim, Y.; Kim, K.; Hong, S.
Org. Biomol. Chem. 2014, 12, 5719.
64. HS-104, a PI3K inhibitor, enhances anticancer efficacy of gemcitabine in pancreatic cancer
Jung, K. H.; Yan, H. H.; Fang, Z.; Son, M. K.; Lee, H.; Hong, S.; Hong, S.-S.
Int. J. Oncol. 2014, 45, 311-321.
63. AgSbF6-Controlled Diastereodivergence in Alkyne Hydroarylation: Facile Access to Z- and E-Alkenyl Arenes
Min, M.; Kim, D.; Hong, S.
Chem. Commun. 2014, 50, 8028.
62. Biophysical characterization of sites of host adaptive mutation in the influenza A virus RNA polymerase PB2 RNA-binding domain
Lim, K.; Kim, M.; Lee, M.-K.; Ko, J.; Hong, S.; Choi, B.-S.
Int. J. Biochem. Cell Biol. 2014, 53, 237.
61. Development and Biological Evaluation of Potent and Selective c-KITD816V Inhibitors
Lee, S.; Lee, H.; Kim, J.; Lee, S.; Kim, S. J. ; Hong, S.-S.; Hong, S.
J. Med. Chem. 2014, 57, 6428.
60. HS-438, a New Inhibitor of Imatinib-Resistant BCR-ABL T315I Mutation in Chronic Myeloid Leukemia
Yun, S.-M., Jung, K. H.; Kim S. J.; Fang, Z. H.; Son, M. K.; Yan, H. H.; Lee, H.; Kim, J.; Shin, S.; Hong, S.*; Hong, S.-S.*
Cancer Lett. 2014, 348, 50.
